NASDAQ$AMTX

Aemetis Inc · Q3 2020 earnings

Q3 2020 earnings · · Investor relations

Briefing

Reported financial results with revenue decreasing due to lower ethanol prices and biodiesel bidding delays in India, but biogas project achieved milestones.

Aemetis, Inc. reported a decrease in revenue to $40.9 million compared to $57.4 million in the third quarter of 2019. The company experienced a net loss of $12.2 million, or $0.59 per share. The Aemetis Biogas team completed the first phase of its dairy digester cluster project.

  • Ethanol and high-grade alcohol gallons sold increased 11% compared to the second quarter of 2020.
  • Biodiesel metric tons sold increased 216% compared to the second quarter of 2020.
  • Revenues were $40.9 million during the third quarter.
  • Net Loss was $12.2 million ($0.59 per share).

Headline financials

Total Revenue

$40.9M

Previous: $57.4M-28.7%
EPS (adj)

-$0.59

Previous: -$0.31-90.3%
Biodiesel Metric Tons Sold

8.1K

No prior period
Capital Expenditures

-$6.3M

Previous: -$4.02M-56.9%
Free Cash Flow

-$18.5M

Previous: -$11.2M-64.7%
Net Income

-$12.2M

Previous: -$7.23M-69.1%
Operating Income

-$3.83M

Previous: -$584K-555.7%
Gross Profit

$771K

Previous: $3.98M-80.6%
Cash & Equivalents

$79K

Previous: $919K-91.4%
Total Assets

$122M

Previous: $96.7M+26.4%
Stock-Based Comp

$191K

Previous: $144K+32.6%

Revenue & EPS history

Aemetis · Revenue · Quarterly

$40.9M

Q3 2020-28.7%vs Q3 2019
Beat estimate in 7 of 16 quarters(44%)
ActualEstimate

Revenue by segment

Aemetis · $7.3M total across 1 segment · Q3 2020

  • India Biodiesel
    $7.3M

Forward guidance

Aemetis expects revenue growth in India during 2021 due to participation in a $900 million India government oil marketing company request to purchase biodiesel.

Tailwinds

  • Expected revenue growth in India during 2021.
  • Aemetis Biogas project is expected to be fully completed within about 18 months.
  • Aemetis will be able to inject dairy renewable natural gas into the common carrier pipeline in 2021.
  • Aemetis will utilize an onsite renewable compressed natural gas fueling station in 2021.
  • Sales of new sanitizer products are planned to be supported by production of United States Pharmacopeia medical grade alcohol beginning in the first half of 2021.

Headwinds

  • Softened demand for high grade alcohol for sanitizer production during the third quarter of 2020.
  • Lower ethanol prices impacted revenue.
  • Delays in the India government oil marketing companies biodiesel bidding process impacted revenue.
  • Operating loss increased to $3.8 million for the third quarter of 2020.
  • Cash at the end of the third quarter of 2020 was $79 thousand, compared to $656 thousand at the end of 2019.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q3 2020

Historical avgQ3 2020

-3.5%

Avg return

Earnings day

-3.2%

Avg return

5 days after

-2.6%

Avg return

30 days after

32%

20 / 62 earnings

Positive

+29.3%

Q4 2020

Best reaction

-37.5%

Q2 2010

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-4.0%-30.2%-30.6%
Q4 2025+25.5%+77.3%+47.4%
Q3 2025-13.2%+4.9%-26.2%
Q1 2025+7.1%+16.2%+50.0%
Q4 2024-6.1%+11.3%-9.3%
Q3 2024+15.0%+6.7%-15.0%
Q2 2024-22.4%-17.8%-23.4%
Q1 2024-3.4%-1.4%-25.1%
Q4 2023+1.2%-3.0%+57.2%
Q3 2023-1.3%+0.2%-0.7%
Q2 2023+9.5%+4.8%-28.3%
Q1 2023-13.8%-11.1%+126.7%
Q4 2022-23.6%-21.3%-42.1%
Q3 2022-0.6%-7.6%-19.3%
Q2 2022+29.2%+29.1%+6.7%
Q1 2022+9.3%+17.1%+4.3%
Q4 2021-7.2%-27.1%-18.6%
Q3 2021+3.3%-4.0%-14.9%
Q2 2021+4.0%-6.0%+40.4%
Q1 2021-27.5%-18.2%+13.8%
Q4 2020+29.3%+14.3%+62.0%
Q3 2020-36.7%-36.1%-35.5%
Q2 2020-26.6%-8.4%-36.2%
Q1 2020+6.9%+11.4%+15.0%
Q4 2019-8.1%-30.9%-15.5%
Q3 2019-2.9%-7.8%-1.9%
Q2 2019-4.1%-6.3%-17.3%
Q1 2019-14.6%-10.8%-32.3%
Q4 2018-0.3%-5.9%-7.1%
Q3 2018-4.0%-5.9%-25.6%
Q2 2018-8.1%-7.4%-10.3%
Q1 2018-0.5%-2.7%-20.7%
Q4 2017-21.5%-17.0%-11.0%
Q3 2017-3.9%-8.9%-12.6%
Q2 2017+2.6%+0.7%-21.1%
Q1 2017-8.8%-11.6%+6.1%
Q4 2016-0.8%+0.0%+0.7%
Q3 2016+11.8%+0.6%+0.2%
Q2 2016+0.0%-12.4%-30.6%
Q1 2016+6.2%
Q4 2015-5.6%
Q3 2015+2.3%
Q2 2015-1.5%
Q1 2015-8.0%
Q4 2014-9.4%
Q3 2014-14.3%
Q2 2014-14.7%
Q1 2014+23.7%
Q4 2013+10.5%
Q3 2013-20.0%
Q2 2013-7.4%
Q1 2013-6.1%
Q4 2012-6.1%
Q3 2011-5.8%
Q2 2012-12.5%
Q3 2012-12.5%
Q2 2011+12.5%
Q1 2011-7.7%
Q4 2010+7.1%
Q3 2010+1.0%
Q2 2010-37.5%
Q1 2010+0.0%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro